California News

Tuesday, May 7, 2013

  • Posted at 1:06 PM
  • Posted at 1:05 PM
    ValueClick, Inc. (NASDAQ: VCLK) today reported financial results for the first quarter ended March 31, 2013. Revenue was within its guidance range, while adjusted-EBITDA1, GAAP net income from continuing operations per diluted share, and non-GAAP net income2 per diluted share exceeded the high-end of their respective ... read more
  • Posted at 1:05 PM
    Demand Media, Inc. (NYSE: DMD), a leading digital media and domain services company, today reported financial results for the first quarter ended March 31, 2013. “Strong growth from our owned & operated content and media properties ... read more
  • Posted at 1:05 PM
    Pulse Electronics Corporation (NYSE:PULS), a leading provider of electronic components, today reported results for its first quarter ended March 29, 2013. First Quarter Highlights ... read more
  • Posted at 1:05 PM
    LA JOLLA, Calif., May 7, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights for the quarter ended March 31, 2013 on Tuesday, May 14, 2013, after the U.S. financial markets close. Regulus will host a conference call and webcast on Tuesday, May 14, 2013 at 5:00 pm Eastern Daylight Time to discuss its first quarter 2013 financial results and ... read more
  • Posted at 1:05 PM
    Cepheid (NASDAQ: CPHD) today announced that it has appointed Warren C. Kocmond to the position of Executive Vice President, Global Operations, effective May 6, 2013. Mr. Kocmond joins Cepheid from Lam Research Corporation, where he most recently served as Vice President of Global Operations, responsible for globally dispersed operations including a multi-billion dollar supply chain. Prior to Lam Research, Mr. Kocmond was Executive Vice President of Global Operations and Quality at Verigy, Ltd., now a wholly owned subsidiary of ... read more
  • Posted at 1:05 PM
    Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today reported pro forma operating income of $4.5 million and pro forma net income of $1.2 million for the three months ended March 31, 2013 compared to a pro forma net operating loss of $16.2 million and a pro forma net loss of $21.7 million for the same period in 2012. The significant improvement in the Company's financial results was driven primarily by milestone payments Isis earned in the first quarter, including a $25 ... read more
  • Posted at 1:05 PM
    SAN JOSE, Calif., May 7, 2013 /PRNewswire/ -- Oclaro, Inc. (NASDAQ: OCLR), a provider of optical components, modules and subsystems, today announced the financial results for its third quarter of fiscal year 2013, which ended March 30, 2013. Oclaro also announced it has secured $25 million in short-term bridge loans from Providence Equity Capital Markets, who joins Wells Fargo Bank and Silicon Valley Bank as a lender under Oclaro's existing credit agreement. "Our financial results were at the lower end of guidance ... read more
  • Posted at 1:04 PM
    Amgen (NASDAQ:AMGN) today announced that the Phase 3 head-to-head ASPECCT ('763) trial evaluating Vectibix(®) (panitumumab) versus Erbitux(®) (cetuximab) as a single agent for the treatment of chemorefractory metastatic colorectal cancer (mCRC) in patients with wild-type KRAS tumors (n=1,010) met its primary endpoint of non-inferiority for overall survival. The estimated overall survival hazard ratio (Vectibix/Erbitux) was 0.966 (95 percent CI: 0.839, 1.113) favoring the Vectibix arm. Overall, the relative adverse event profiles were as anticipated for each of the anti-EGFR therapies studied, ... read more
  • Posted at 1:03 PM
    Live Nation Entertainment (NYSE: LYV) today released financial results for the three months ended March 31, 2013. "We are pleased with our first quarter revenue growth of 6% as compared to last year, driven by a 12% increase in concert attendance. This good start to the year reaffirms the strength and stability of our platforms heading into 2013, and through April 2013, our concert ticket sales for all events this year are up 26% and Ticketmaster ticket counts ... read more
  • Posted at 1:01 PM
  • Posted at 1:01 PM
    Anacor Pharmaceuticals (NASDAQ:ANAC) will release its financial results for the first quarter ended March 31, 2013, on Thursday, May 9, 2013 at approximately 4:00 p.m. ET / 1:00 p.m. PT. The announcement will be followed by a conference call at 5:00 p.m. ET / 2:00 p.m. PT during ... read more
  • Posted at 1:01 PM
    ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the first quarter ended March 31, 2013. ... read more
  • Posted at 1:01 PM
    Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. Through the publication of CEO notes, I seek to provide shareholders and other interested parties with a level of corporate transparency often absent in the microcap marketplace. In recent notes, I reviewed various topics, including emerging opportunities in cancer and the expansion of our government contract program to create a sepsis therapeutic. This note is specific to our most important near-term objective: the ... read more
  • Posted at 1:00 PM
    InSite Vision Incorporated (OTCBB: INSV) today reported financial results for the quarter ended March 31, 2013. Revenues for the first quarter of 2013 were $5.3 million compared to $2.3 million for the same period in 2012. Net loss for the first quarter of 2013 was $1.9 million, ... read more
  • Posted at 1:00 PM
  • Posted at 12:35 PM
    MadeMan.com, Break Media's leading online men's lifestyle platform, announces the launch of a new original web series with NIVEA MEN, inspired by the grooming brand's new "Silence the Irritation" campaign. On May 7(th), MadeMan.com will premiere Just Face It, starring Damon Wayans Jr. (Happy Endings) and written by Chadd Gindin (It's Always Sunny, The Cleveland Show, Up All Night). The eight episode comedy series follows Wayans' character as he juggles his diverse crew of friends, co-workers and ongoing pursuit of ... read more
  • Posted at 12:30 PM
    Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing BELVIQ( )(pronounced BEL-VEEK) into Schedule IV of the Controlled Substances Act. The scheduling designation will be effective 30 days after tomorrow's expected publication in the Federal Register. Following the effective date, BELVIQ will be available to patients in the United States by prescription, and Arena will receive $65 million in milestone payments from ... read more
  • Posted at 12:05 PM
    CytomX Therapeutics, a biotechnology company developing a new generation of highly targeted antibody therapeutics, announced today it has been selected as a finalist for Red Herring’s Top 100 North America award, a prestigious list honoring the year’s most promising private ... read more
  • Posted at 12:00 PM
    In a move signifying the further digitization of content and the need to provide 24/7 access to the latest experiential news, research and thought leadership, Event Marketer magazine, the number one ranked experience marketing agency George P. Johnson and its sister agency JUXT, a strategic design ... read more